Allelic Imbalances of the egfr Gene as Key Events in Breast Cancer Progression – the Concept of Committed Progenitor Cells
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
431-445
Author(s):
K. Agelopoulos, H. Buerger and B. Brandt
Recent Trends in Targeted Anticancer Prodrug and Conjugate Design
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
1802-1826
Author(s):
Yashveer Singh, Matthew Palombo and Patrick J. Sinko
Therapeutical Relevance of MAP-Kinase Inhibitors in Renal Diseases: Current Knowledge and Future Clinical Perspectives
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
2054-2070
Author(s):
M. Teresa Grande and Jose M. Lopez-Novoa
Role of mTOR in Hematological Malignancies
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
211-218
Author(s):
Uzma Athar and Ajeet Gajra
New Developments in Systemic Therapy for Hepatocellular Carcinoma
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
219-226
Author(s):
Spyros P. Dourakis
The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
227-234
Author(s):
Arun Rajan and Ajeet Gajra
Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2229-2251
Author(s):
George S. Papaetis, Lena M. Karapanagiotou, Hardev Pandha and Kostas N. Syrigos
Sequential Bilateral Internal Jugular Vein Thrombosis: A Case Report and Review of this Rare Medical Entity
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
5
Page:
169-173
Author(s):
Ioannis Starakis, Dimitrios Siagris, Eftichia Polyzogopoulou and Elias Mazokopakis
Editorial [ Hot Topic: Wnt Signaling (Guest Editor: Rashna D. Balsara) ]
Journal:
Current Drug Targets
Volume:
9
Page:
511-512
Author(s):
Rashna D. Balsara
Wnt Signaling in Renal Cancer
Journal:
Current Drug Targets
Volume:
9
Page:
591-600
Author(s):
Hector Guillen-Ahlers